Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ferrara
Clinical trial register · Italy

Clinical Trials in Ferrara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital of Ferrara23 Università degli Studi di Ferrara7 IRCCS Azienda Ospedaliero-Universitaria di Bologna6 Eli Lilly and Company5 F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore4
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Ferrara

138 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Chieti, Bari, Castellana Grotte (BA), Catanzaro, Cosenza, Naples, Salerno, Ferrara
2026-10-26
Not yet open
Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia
NCT07806474Androgenic Alopecia, Healthy Adult Male
Activ'inside
Not applicable
99
Rende, Ferrara, Garbagnate Milanese, Milan, Biella, San Martino Siccomario
2026-09-30
Not yet open
University Hospital of Ferrara
Not applicable
200
Ferrara
2026-09-30
Not yet open
Azienda USL Reggio Emilia - IRCCS
Observational
210
Bari, Bologna, Ferrara, Meldola, Milan, Modena, Naples, Reggio Emilia
2026-08-30
Recruiting
Iron Deficiency at ICU Discharge
NCT07781540Anemia, Post ICU Syndrome, Red Blood Cell Transfusions, Iron Deficiencies
Università degli Studi di Ferrara
Observational
462
Ferrara, Roma, Siena
2026-07-29
Recruiting
University Hospital of Ferrara
Not applicable
12
Ferrara
2026-06-01
Recruiting
University Hospital of Ferrara
Not applicable
1,612
Andria, Arezzo, Bologna, Ferrara, Grosseto, L’Aquila, Mirano, Ravenna
2026-05-25
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Chieti, Cosenza, Naples, Bentivoglio, Bologna, Ferrara, Reggio Emilia, Udine
2026-05-11
Active, closed
Novo Nordisk A/S
Phase 3
606
Ferrara, Genoa, Pavia, Palermo, Padova, Verona, Bologna, Rozzano (MI)
2026-04-21
Recruiting
Visugromab in Cachexia International Trial
NCT07112196Cancer-associated Cachexia
DrugsVisugromab·Visugromab RDE
CatalYm GmbH
Phase 2/3
518
Aviano, Brescia, Ferrara, Meldola, Verona
2026-04-16
Recruiting
AstraZeneca
Phase 3
245
Brescia, Catania, Ferrara, Florence, Milan, Padova, Pisa, Roma
2026-04-13
Not yet open
Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
NCT07295522Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)
DrugGDMT
IRCCS Policlinico S. Donato
Phase 4
368
San Donato Milanese, Ancona, Bari, Cecina, Ferrara, Florence, Milan, Pisa
2026-04-08
Recruiting
Amgen
Phase 3
406
Ferrara, Milan, San Donato Milanese, Torino
2026-03-23
Recruiting
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block
Boston Scientific Corporation
Observational
140
Ferrara, Milan, Novara
2025-12-19
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,260
Bari, Bologna, Catania, Ferrara, Milan, Novara, Palermo, Parma
2025-12-03
Not yet open
University Hospital of Ferrara
Not applicable
124
Ferrara
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bologna, Brescia, Ferrara, Florence, Genova, Milan, Monza, Palermo
2025-12-01
Recruiting
Debiopharm International SA
Phase 3
119
Ferrara, Genova, Milan, Naples, Padova, Roma, Torino
2025-11-26
Recruiting
University Hospital of Ferrara
Not applicable
156
Ferrara
2025-11-15
Recruiting
ASMact: Study on Management of Bronchial Asthma
NCT07412769Asthma Acute, Asthma Childhood, Asthma in Children, Asthma Crisis
Meyer Children's Hospital IRCCS
Observational
500
Ferrara, Florence
2025-11-05
Recruiting
Bristol-Myers Squibb
Observational
223
Ferrara, Torino, Brescia
2025-10-08
Recruiting
VisionCare, Inc.
Not applicable
44
Bari, Bergamo, Ferrara, Florence, Roma
2025-09-23
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Arzignano, Baggiovara, Bologna, Caserta, Ferrara, Ferrara (Cona), Florence, Genova
2025-09-02
Not yet open
University Hospital of Ferrara
Not applicable
120
Ferrara
2025-08-15
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
50
Bari, Meldola, Ferrara, Genova, Lido di Camaiore, Lucca, Monza, Milan
2025-08-12
Recruiting
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
NCT06927739Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease
Abcentra
Phase 2
240
Caserta, Ferrara, Brescia, Milan, Pavia
2025-08-11
Recruiting
AstraZeneca
Phase 2
987
Busto Arsizio, Cuneo, Ferrara, Milan, Monza, Naples, Pavia, Roma
2025-06-27
Recruiting
GlaxoSmithKline
Phase 3
961
Castelvenere, Foggia, Roma, Catania, Ferrara, Genova, Rozzano
2025-06-23
Recruiting
BeOne Medicines
Phase 3
630
Bari, Cagliari, Catania, Ferrara, Milan, Modena, Pagani
2025-06-11
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
100
Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Genova, Messina
2025-06-01
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Orbassano, Bari, Bologna, Cagliari, Cuneo, Ferrara, Florence, Genova
2025-06-01
Recruiting
Spontaneous Eye Blinking in Disorders of Consciousness
NCT06323031Disorders of Consciousness
Fondazione Don Carlo Gnocchi ETS
Observational
70
Sant'Angelo dei Lombardi, Ferrara, Florence, Milan
2025-05-08
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Ferrara, Mestre, Monza, Rivoli, Vicenza
2025-05-06
Recruiting
Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)
NCT06965023ST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure
Azienda Ospedaliera "Sant'Andrea"
Observational
130
Roma, Caserta, Catania, Ferrara, Forlì, Milan, Naples, Turin
2025-04-22
Recruiting
University Hospital of Ferrara
Not applicable
52
Ferrara
2025-03-15
Not yet open
Università degli Studi di Ferrara
Phase 2/3
20
Ferrara
2025-03-01
Not yet open
Consorzio Oncotech
Observational
1,000
Avellino, Bergamo, Bologna, Brescia, Termoli, Caserta, Cuneo, Ferrara
2025-03
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
NCT06823466Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF), Outcome Assessment
University of L'Aquila
Observational
200
Ancona, Bari, Bologna, Città di Castello, Ferrara, Florence, Frosinone, L’Aquila
2025-02-12
Recruiting
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
NCT07174102Reumatoid Arthritis, Interstitial Lung Disease Due to Systemic Disease (Disorder), Idiopathic Pulmonary Fibrosis (IPF), Connective Tissue Disease (CTD)
Azienda Unita Sanitaria Locale di Piacenza
Observational
500
Ferrara, Modena, Piacenza, Reggio Emilia
2025-01-08
Recruiting
Università degli Studi di Ferrara
Not applicable
150
Ferrara
2025-01-07
Recruiting
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
NCT06836011ATTR Amyloidosis With Cardiomyopathy, ATTR-CM, ATTR Amyloidosis Wild Type, Mitral Regurgitation
Medical University of Vienna
Observational
600
Brescia, Ferrara, Trieste
2025-01-01
Recruiting
Santen SAS
Phase 3
234
Ferrara, Naples, Roma
2024-12-30
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
212
Alessandria, Ancona, Ascoli Piceno, Bari, Biella, Bologna, Bolzano, Ferrara
2024-12-13
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
59
Alessandria, Bologna, Catania, Cosenza, Ferrara, Meldola, Milan, Padova
2024-12-09
Recruiting
University Hospital Freiburg
Not applicable
20,000
Rome, Ferrara, Modena, Roma
2024-12-03
By invitation
University Hospital of Ferrara
Observational
600
Ferrara
2024-11-30
Active, closed
Istituto Oncologico Veneto IRCCS
Phase 2
41
Bergamo, Roma, Rozzano, Aviano, Alessandria, Ferrara, Padova, Parma
2024-11-06
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
300
Bari, Bologna, Cagliari, Ferrara, Florence, Foggia, Genova, Messina
2024-11-04
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Alessandria, Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Foggia
2024-11-04
Recruiting
University Hospital of Ferrara
Not applicable
18
Ferrara
2024-10-28
Recruiting
University Hospital of Ferrara
Not applicable
18
Ferrara
2024-10-15
Recruiting
Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528Primary Cardiac Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
43
Bergamo, Brescia, Ferrara, Milan, Perugia, Pisa, Roma, Sassari
2024-10-02
Recruiting
Exercise Activity to Improve Mobility in Patients With CKD and PAD
NCT06621264Chronic Kidney Disease Stage 3 and 4, Peripheral Artery Disease (PAD)
University Hospital of Ferrara
Not applicable
124
Ferrara, Peschiera del Garda, Reggio Calabria
2024-10-01
Active, closed
Regeneron Pharmaceuticals
Phase 2
19
Ferrara
2024-09-30
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Ferrara, Milan, Naples, Roma
2024-09-19
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Cuneo, Ferrara, Milan, Naples, Novara, Pisa, Rome, Taormina
2024-09-18
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Ferrara, Genova, Milan, Pisa, Roma, Torino, Verona
2024-09-17
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Catanzaro, Caserta, Naples, Bologna, Ferrara, Modena, Genova, Catania
2024-09-09
Recruiting
SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
NCT06373601Coronary Artery Disease, Stenosis Coronary, Coronary Artery Lesion, Percutaneous Coronary Intervention
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Not applicable
140
Mercogliano, Bergamo, Brescia, Ferrara, Milan, Rozzano, Naples, Orbassano
2024-09-05
Recruiting
Non-pharmacological Care for Depression in Cancer Patients Using VR and TMS
NCT06589544Depressive Symptoms, Quality of Life, Cognitive Impairment
University Hospital of Ferrara
Not applicable
100
Ferrara, Cagliari
2024-08-21
Active, closed
GlaxoSmithKline
Phase 3
10,212
Negrar, Alessandria, Bari, Belluno, Ferrara, Naples, Palermo, Pessione - Chieri to
2024-08-01
Recruiting
NovoCure GmbH
Phase 3
734
Alessandria, Bergamo, Ferrara, Meldola, Pesaro, Roma, Rome, Siena
2024-07-31
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Naples, Ferrara, Piacenza, Florence, Livorno, Bergamo, Milan, Pesaro
2024-07-16
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
4,000
Bologna, Brindisi, Brescia, Cuneo, Como, Cremona, Ferrara, Genova
2024-06-28
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
DrugTagraxofusp
Stemline Therapeutics, Inc.
Observational
80
Alessandria, Bologna, Catania, Cuneo, Ferrara, Florence, Genova, Milan
2024-06-26
Recruiting
How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study
NCT06872632Complexity and Multiple Illnesses of Adult Hospitalized Internal Medicine Patient
Società Italiana di Medicina Interna
Observational
2,326
Bari, Bologna, Brescia, Ferrara, Florence, Messina, Milan, Modena
2024-06-24
Active, closed
GlaxoSmithKline
Phase 4
303
Brescia, Ferrara, Milan, Pisa, Reggio Emilia, Rome, Rozzano
2024-06-06
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Bari, Ferrara, Florence, Milan, Novara, Padova, Palermo, Perugia
2024-05-30
Recruiting
PENTA Foundation
Not applicable
3,080
Ferrara, Modena, Palermo, Vicenza
2024-05-28
Recruiting
Angelina Passaro
Observational
150
Ferrara, Poggio Renatico
2024-05-14
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bologna, Ferrara, Genova, Milan, Palermo, Perugia, Pisa, Roma
2024-04-30
Recruiting
CSL Behring
Phase 2/3
3,110
Bologna, Brescia, Cagliari, Caserta, Catania, Ferrara, Florence, Foggia
2024-04-27
Recruiting
University Hospital of Ferrara
Observational
60
Ferrara
2024-04-16
Recruiting
University Hospital of Ferrara
Not applicable
236
Ferrara, Naples
2024-03-08
Active, closed
Eli Lilly and Company
Phase 3
17,300
Arzignano, Baggiovara, Bologna, Cinisello Balsamo, Ferrara, Florence, Genova, Milan
2024-03-05
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
96
Bologna, Caserta, Catania, Ferrara, Florence, Milan, Novara, Palermo
2024-03-01
Recruiting
medac GmbH
Phase 3
277
Arezzo, Ferrara, Florence, Naples, Parma, Pisa
2024-02-27
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Bologna, Ferrara, Florence, Forlì, Messina, Milan, Naples, Padova
2024-01-11
Recruiting
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
NCT06356727Heart Failure, Left Ventricular Dysfunction, Idiopathic Dilated Cardiomyopathy
Azienda Ospedaliera Universitaria Integrata Verona
Not applicable
190
Ferrara, Genova, Milan, Naples, Roma, Rome, Torino, Verona
2024-01-03
Recruiting
Effect of Goal-directed Analgesia and Sedation Using EEG Derived QCON/qNOX in ICU Patients
NCT06769308Sedation Complication, Mechanical Ventilation Complication
Università degli Studi di Ferrara
Not applicable
174
Ferrara, Naples
2024-01-01
Recruiting
Multicenter Evaluation of Patients Using LATITUDE Monitoring System
NCT06311149Cardiovascular Diseases, Arrhythmias, Cardiac, Heart Failure, Sudden Cardiac Death
University Hospital of Ferrara
Observational
20,000
Ferrara, Naples, Roma
2023-12-01
Active, closed
BeOne Medicines
Phase 3
652
Bologna, Ferrara, Milan, Novara, Padova, Perugia
2023-11-11
Recruiting
Oxygen Extraction-guided Transfusion
NCT06102590Blood Transfusion
Università degli Studi di Ferrara
Not applicable
324
Ferrara, Perugia, Siena
2023-11-04
Recruiting
Federico II University
Phase 4
80
Ferrara, Naples
2023-11-01
Active, closed
Standardizing the Management of Patients With Coronary Microvascular Dysfunction
NCT06025994Coronary Artery Disease, Microvascular Angina, Microvascular Ischemia of Myocardium
Consorzio Futuro in Ricerca
Not applicable
123
Ferrara, Parma
2023-10-10
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
DrugBelimumab
GlaxoSmithKline
Phase 2/3
300
Roma, Ancona, Bari, Cagliari, Catania, Ferrara, Florence, Milan
2023-09-13
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
2,772
Ferrara, Padova, Pisa, Verona
2023-08-30
Active, closed
Mineralys Therapeutics Inc.
Phase 3
1,076
Bologna, Ferrara, Genova, Messina, Pisa, Roma
2023-07-14
Recruiting
Population Health Research Institute
Not applicable
5,100
Arezzo, Bologna, Ferrara, Grosseto, Reggio Emilia, Rome
2023-06-22
Active, closed
University Hospital of Ferrara
Not applicable
1,823
Bologna, Ferrara, Bolzano, Catanzaro, Cosenza, Baggiovara, Piacenza, Parma
2023-05-08
Active, closed
Azienda Usl di Bologna
Not applicable
657
Bologna, Arezzo, Asti, Biella, Ferrara, Forlì, Grosseto, Mirano
2023-05-01
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Arezzo, Aversa, Bergamo, Bologna, Caserta, Catania, Catanzaro, Ferrara
2023-04-11
Recruiting
University Hospital of Ferrara
Not applicable
48
Ferrara
2023-03-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
65
Bologna, Caserta, Bari, Ferrara, Florence, Milan, Novara, Padova
2023-03-01
Recruiting
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
NCT06324682Arrhythmias, Cardiac, Atrioventricular Block, Reduced Systolic Function, Atrial Fibrillation
University Hospital of Ferrara
Observational
8,400
Ferrara, Arezzo, Bologna, Carpi, Cento, Cesena, Empoli, Fidenza
2023-01-01
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Battipaglia, Naples, Ferrara, Pavia, Catania, Palermo
2022-12-29
Recruiting
Montreal Heart Institute
Phase 3
10,000
Foggia, Acquaviva delle Fonti, Ferrara, Ravenna, Milan, Turin, Ancona, Florence
2022-12-21
Recruiting
The CATALINA Study
NCT05008081Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens
Observational
1,000
Ferrara
2022-10-25
Active, closed
Eli Lilly and Company
Phase 3
15,374
Bari, Bologna, Como, Ferrara, Florence, Latina, Padova, Palermo
2022-10-11
Recruiting
Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)
NCT05601700Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary
DrugLetrozole
Ente Ospedaliero Ospedali Galliera
Phase 3
132
Arezzo, Ponderano, Belluno, Brescia, Como, Meldola, Ferrara, Genova
2022-09-22
Recruiting
INSIGHTFUL-FFR Clinical Trial
NCT05437900Coronary Artery Disease, Acute Coronary Syndrome
CoreAalst BV
Phase 4
2,500
Ferrara, La Spezia, Latina, Naples, Rome
2022-09-22
Recruiting
Atrial Fibrillation in Beta-Thalassemia
NCT05508932Atrial Fibrillation, Thalassemia
University Hospital of Ferrara
Observational
350
Ferrara
2022-09-01
Recruiting
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Bergamo, Ferrara, Genova, Milan, Naples, Roma
2022-07-22
Active, closed
Implant-supported Rehabilitation With SPAL Technique or Soft Tissue Augmentation
NCT05610748Dehiscence, Alveolar Ridge Enlargement, Bone Loss, Alveolar
Università degli Studi di Ferrara
Phase 4
66
Ferrara
2022-07-01
Recruiting
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
NCT06516406Myelofibrosis, Primary Myelofibrosis, Secondary Myelofibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,055
Cosenza, Reggio Calabria, Naples, Bologna, Ferrara, Parma, Piacenza, Ravenna
2022-05-06
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Not applicable
100
Meldola, Bologna, Ferrara, Parma, Piacenza, Ravenna, Reggio Emilia, Rimini
2022-03-01
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Ferrara, Milan, Naples, Palermo, Pavia, Rozzano, Terni
2022-02-07
Active, closed
Società Italiana Talassemie ed Emoglobinopatie
Observational
1,000
Torino, Cagliari, Ferrara, Genova, Milan, Naples, Palermo, Roma
2022-01-01
Active, closed
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
NCT04770753Non-Transfusion-dependent Alpha-Thalassemia, Non-Transfusion-dependent Beta-Thalassemia
DrugMitapivat
Agios Pharmaceuticals, Inc.
Phase 3
194
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-12-20
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3
162
Meldola, Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Mestre
2021-12-14
Active, closed
NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)
NCT04969471Segment Elevation Myocardial Infarction (STEMI)
Vesalio
Not applicable
148
Ferrara, Milan, Roma
2021-12-09
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Brindisi, Cagliari, Ferrara, Genova, Milan, Modena, Naples, Orbassano
2021-11-30
Active, closed
argenx
Phase 3
173
Ferrara, Milan, Naples
2021-11-17
Active, closed
Multimodal Prehabilitation in Colorectal Cancer Patients
NCT06443203Colon Cancer, Prehabilitation
University Hospital of Ferrara
Not applicable
112
Ferrara
2021-06-15
Active, closed
University Hospital of Ferrara
Not applicable
249
Ferrara, Bologna, Forlì, Palermo, Ravenna, Rimini, Trieste
2021-06-03
Active, closed
Alfasigma S.p.A.
Observational
1,304
Bari, Brescia, Catania, Ferrara, Genova, Milan, Naples, Roma
2021-05-11
Active, closed
Azienda USL Reggio Emilia - IRCCS
Observational
700
Reggio Emilia, Bologna, Ferrara, Forlì, Modena, Parma, Rimini
2021-05-10
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Bergamo, Bologna, Brescia, Ferrara, Florence, Meldola, Milan, Monza
2021-04-09
Active, closed
German CLL Study Group
Phase 3
897
Catania, Ferrara, Mestre, Milan, Perugia, Roma, Torino
2021-03-01
Active, closed
IRCCS San Raffaele Roma
Not applicable
70
Bologna, Ferrara, Foggia, Messina, Roma, Rome, San Giovanni Rotondo
2020-12-28
Active, closed
Pullback Pressure Gradient (PPG) Global Registry
NCT04789317Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction
VZW Cardiovascular Research Center Aalst
Observational
982
Ferrara, Rome
2020-12-23
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Bologna, Torino, Ferrara, Meldola, Rome, Roma, Brescia, Milan
2020-11-25
Recruiting
Unity Health Toronto
Not applicable
740
Ferrara, Foggia, Rome
2020-11-23
Active, closed
Bayer
Phase 4
654
Ferrara, Modena, Parma, Aviano, Rome, Genoa, Milan, Alessandria
2020-11-09
Recruiting
University of Turin, Italy
Not applicable
416
Grosseto, Sesto San Giovanni, La Spezia, Candiolo, Pinerolo, Bologna, Ferrara, Genova
2020-07-13
Active, closed
University Hospital of Ferrara
Not applicable
512
Bologna, Ferrara, Piacenza, Lagosanto
2020-03-27
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Florence, Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Genoa, Lecce
2019-08-12
Recruiting
University of Milano Bicocca
Observational
7,000
Baggiovara, Bologna, Bolzano, Carate Brianza, Ferrara, Florence, Genova, Roma
2019-07-15
Active, closed
Consorzio Futuro in Ricerca
Not applicable
1,445
Bologna, Ferrara, Cotignola, Ravenna, Reggio Emilia, Rimini, Agrigento, Caserta
2019-07-15
Active, closed
The European Robotic Spinal Instrumentation (EUROSPIN) Study
NCT03398915Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis, Recurrent Disc Herniation
Marc Schröder
Observational
932
Cesena, Ferrara, Messina, Roma
2019-01-01
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Bergamo, Candiolo, Carpi, Catania, Ferrara, Lecco, Livorno, Milan
2018-04-05
Recruiting
University Hospital of Ferrara
Observational
200
Ferrara
2017-11-01
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Ferrara, Rome
2017-07-05
Recruiting
Boston Scientific Corporation
Observational
300
Ferrara, Mestre, Rome, Udine
2016-03-07
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Ferrara, Florence, Genoa, Grosseto, Legnago, Meldola, Milan, Monza
2015-08
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,507
Brixen, Merano, Mirano, Bologna, Bolzano, Ferrara, Reggio Emilia
2014-09
Recruiting
Boston Scientific Corporation
Observational
1,500
Arcugnano, Ferrara, Mestre, Milan, Pavia, Rome, Udine
2014-03-04
Recruiting
Integrating Exercise Into Lifestyle of Cardiac Outpatients
NCT05817305Cardiovascular Diseases, Physical Inactivity, Aging, Quality of Life
Università degli Studi di Ferrara
Observational
5,000
Ferrara
1997-01-01
Rows per page Showing 1–138 of 138
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/ferrara

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 138 of those studies with a site in Ferrara.

How many clinical trials are recruiting in Ferrara?

78 of the 138 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 11 have not yet opened recruitment, 48 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ferrara), 138 studies
PhaseStudiesRecruitingShare
Observational443131.9%
Not applicable382327.5%
Phase 3341524.6%
Phase 2825.8%
Phase 4735.1%
Phase 2/3543.6%
Phase 1/2201.4%

Most active sponsors

Lead sponsors with the most studies (Ferrara)
Lead sponsorStudiesRecruiting
University Hospital of Ferrara2315
Università degli Studi di Ferrara75
IRCCS Azienda Ospedaliero-Universitaria di Bologna65
Eli Lilly and Company52
Boston Scientific Corporation43
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore42
GlaxoSmithKline42
Janssen Research & Development, LLC41
Novo Nordisk A/S31
Regeneron Pharmaceuticals30
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.